Amylyx Pharmaceuticals, Inc. Balance Sheet

Balance Sheet Dec2021 Dec2022 Dec2023 Dec2024
Assets
Assets 105.61M391.45M517.45M193.63M
Current Assets
Cash & Equivalents 50.19M62.53M170.20M77.39M
Short-term Investments 45.93M284.42M201.16M99.11M
Cash & Current Investments 96.12M346.94M371.36M176.50M
Receivables - Net 15.31M40.05M0.45M
Receivables - Other 0.50M0.50M0.10M
Receivables 15.81M40.55M0.55M
Raw Materials 7.15M
Work In Process 1.68M
Finished Goods 0.94M
Inventory 9.77M38.32M
Prepaid Assets 5.39M10.11M14.93M12.48M
Current Assets 104.95M382.13M464.67M189.43M
Non-Current Assets
Property, Plant & Equipment (Net) 0.47M2.61M2.69M0.96M
Other Non-Current Assets 0.20M0.47M0.70M0.02M
Non-Current Assets 0.66M9.32M52.79M4.20M
Liabilities
Current Liabilities
Accounts Payables 4.37M6.26M22.06M2.94M
Payables 4.37M6.26M22.06M2.94M
Accumulated Expenses 13.02M38.31M57.72M23.95M
Other Accumulated Expenses 0.26M1.00M
Current Leases 2.04M2.26M1.52M
Total Current Liabilities 17.40M46.61M82.04M28.41M
Non-Current Liabilities
Non-Current Deffered Revenue 0.04M
Preferred Stock Liabilities 239.35M
Operating Leases 4.24M1.98M0.46M
Liabilities
Total Liabilities 17.43M50.85M84.02M28.87M
Shareholder's Equity
Common Equity -151.17M340.61M433.43M164.76M
Shareholder's Equity -151.17M340.61M433.43M164.76M
Liabilities and Shareholders Equity 105.61M391.45M517.45M193.63M
Retained Earnings -155.84M-354.22M-304.95M-606.69M
Treasury Shares 0.74M1.11M2.21M